Motley Fool Asset Management’s Elevance Health ELV Stock Holding History

Motley Fool Asset Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-55,000	Closed	-$7.91M	–	70
2016 Q4	$7.91M	Hold	55,000	–	–	1.76%	25
2016 Q3	$6.89M	Hold	55,000	–	–	1.52%	27
2016 Q2	$7.22M	Sell	55,000 -23,697	-30%	-$3.24M	1.58%	25
2016 Q1	$10.9M	Hold	78,697	–	–	2.29%	12
2015 Q4	$15.3M	Sell	78,697 -31,000	-28%	-$4.27M	3.07%	6
2015 Q3	$15.4M	Hold	109,697	–	–	3.01%	6
2015 Q2	$18M	Hold	109,697	–	–	3.2%	5
2015 Q1	$16.9M	Hold	109,697	–	–	2.98%	7
2014 Q4	$13.8M	Hold	109,697	–	–	2.59%	9
2014 Q3	$13M	Sell	109,697 -25,000	-19%	-$2.87M	2.68%	8
2014 Q2	$14.5M	Buy	134,697 +3,300	+3%	+$340K	3.13%	3
2014 Q1	$13.1M	Hold	131,397	–	–	3.02%	4
2013 Q4	$12.1M	Buy	131,397 +20,000	+18%	+$1.78M	3.05%	4
2013 Q3	$9.31M	Hold	111,397	–	–	2.77%	6
2013 Q2	$9.12M	Buy	+111,397	New	+$8.34M	3.31%	3

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Motley Fool Asset Management's ELV Position: Q1 2017 in Review

Motley Fool Asset Management sold out of Elevance Health (ELV) in Q1 2017, closing a stake of 55,000 shares — an estimated $7.91M sold.

Motley Fool Asset Management first reported a position in ELV in Q2 2013 and held it in 15 quarters. The position peaked at $18M in Q2 2015. 796 funds tracked by Wall St. Rank hold ELV as of Q1 2017.

Motley Fool Asset Management reported no remaining Elevance Health position as of Q1 2017 after selling out during the quarter.
Motley Fool Asset Management sold 55,000 Elevance Health shares in Q1 2017, an estimated $7.91M.
Motley Fool Asset Management first reported a position in Elevance Health in Q2 2013 and held it in 15 quarters.
Motley Fool Asset Management's Elevance Health position peaked at $18M in Q2 2015.
796 funds tracked by Wall St. Rank held Elevance Health as of Q1 2017.

Based on Motley Fool Asset Management's 13F filing for Q1 2017, filed 9 May 2017.